These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 15966415)

  • 1. [Therapeutic strategies for Parkinson's disease].
    Destee A
    Rev Prat; 2005 Apr; 55(7):723-32. PubMed ID: 15966415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacotherapy for Parkinson's disease.
    Chen JJ; Swope DM
    Pharmacotherapy; 2007 Dec; 27(12 Pt 2):161S-173S. PubMed ID: 18041936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Medicinal treatment of idiopathic Parkinson's disease].
    Klockgether T
    Nervenarzt; 2003 Mar; 74 Suppl 1():S12-21. PubMed ID: 12624679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An update on the treatment of Parkinson's disease.
    Jankovic J
    Mt Sinai J Med; 2006 Jul; 73(4):682-9. PubMed ID: 16878274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug insight: Continuous dopaminergic stimulation in the treatment of Parkinson's disease.
    Olanow CW; Obeso JA; Stocchi F
    Nat Clin Pract Neurol; 2006 Jul; 2(7):382-92. PubMed ID: 16932589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 'magic' of L-dopa: why is it the gold standard Parkinson's disease therapy?
    Mercuri NB; Bernardi G
    Trends Pharmacol Sci; 2005 Jul; 26(7):341-4. PubMed ID: 15936832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Parkinson's disease in Thailand: review of the literature and practical recommendations.
    Bhidayasiri R; Ling H
    J Med Assoc Thai; 2009 Jan; 92(1):142-54. PubMed ID: 19260256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying poor symptom control in Parkinson's disease.
    Scott L
    Nurs Times; 2006 Mar 21-27; 102(12):30-2. PubMed ID: 16594560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidelines for the management of Parkinson's disease. The Parkinson's Disease Consensus Working Group.
    Bhatia K; Brooks DJ; Burn DJ; Clarke CE; Playfer J; Sawle GV; Schapira AH; Stewart D; Williams AC
    Hosp Med; 1998 Jun; 59(6):469-80. PubMed ID: 9775275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Motor fluctuations in Parkinson's disease.
    Weiner WJ
    Rev Neurol Dis; 2006; 3(3):101-8. PubMed ID: 17047575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacological treatment of parkinsonian tremor].
    Yokochi F
    Nihon Rinsho; 2000 Oct; 58(10):2091-5. PubMed ID: 11068452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parkinson's goal: ease symptoms, slow progression.
    Johns Hopkins Med Lett Health After 50; 2006 Jun; 18(4):4-5. PubMed ID: 16795901
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of levodopa-induced motor complications.
    Stocchi F; Tagliati M; Olanow CW
    Mov Disord; 2008; 23 Suppl 3():S599-612. PubMed ID: 18781681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinson's disease: diagnosis and treatment.
    Rao SS; Hofmann LA; Shakil A
    Am Fam Physician; 2006 Dec; 74(12):2046-54. PubMed ID: 17186710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkinson's disease: the case for novel treatment strategies.
    Stern MB; Freese A
    Exp Neurol; 1997 Mar; 144(1):2-3. PubMed ID: 9126142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limitations of current Parkinson's disease therapy.
    Rascol O; Payoux P; Ory F; Ferreira JJ; Brefel-Courbon C; Montastruc JL
    Ann Neurol; 2003; 53 Suppl 3():S3-12; discussion S12-5. PubMed ID: 12666094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Initial management and adaptation of Parkinson's disease treatment].
    Gérard JM
    Rev Med Brux; 2008 Sep; 29(4):229-31. PubMed ID: 18949969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkinson's disease: managing symptoms and preserving function.
    Sweeney PJ
    Geriatrics; 1995 Sep; 50(9):24-31. PubMed ID: 7672615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of apomorphine in Parkinson's disease.
    Stocchi F
    Neurol Sci; 2008 Dec; 29 Suppl 5():S383-6. PubMed ID: 19381769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients.
    Prescott IA; Dostrovsky JO; Moro E; Hodaie M; Lozano AM; Hutchison WD
    Brain; 2009 Feb; 132(Pt 2):309-18. PubMed ID: 19050033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.